Initiatives to address social determinants of health are likely to positively change the health care landscape, and better patient education can contribute to more favorable care choices says Ken Cohen, MD, director of translational research for Optum Care.
Initiatives to address social determinants of health are likely to positively change the health care landscape, and better patient education can contribute to more favorable care choices says Ken Cohen, MD, director of translational research for Optum Care.
Transcript
How should data be balanced with what the patient thinks they need?
That's a critically important question. Patients continue to conflate more care with better care, and nothing can be farther from the truth. That's the fault of the medical system because we have not done a very good job of educating patients. The solution to that is sophisticated, shared decision-making modules that can actually teach patients in a way that they can understand and participate with what are the real-world outcomes of the care that they're seeking? When you show them that real-world outcome data, by and large, they will choose the correct care. So, we can do this, but we just haven't done an adequate job to date.
What is the role of data currently doing to address disparities of care?
We're not doing enough, but mostly we're not doing enough not because there's not a desire to improve it. I think across the health care system is recognition of the need to improve. The problem is we haven't measured it adequately at this point, so we don't know where to improve. That's changing. Very, very quickly people are adapting to that and beginning to rigorously measure social determinants of health. Once we have an accurate landscape to know where there are deficiencies and how those can be improved, then resources are available to be applied to that, and I think the landscape will change very quickly.
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Mirvetuximab Soravtansine-gynx Granted Full FDA Approval for FRα+ Platinum-Resistant Ovarian Cancer
March 22nd 2024Mirvetuximab soravtansine-gynx (Elahere) received full FDA approval for the treatment of folate receptor alpha–positive (FRα+), platinum-resistant ovarian cancer (PROC) based on findings from the confirmatory phase 3 MIRASOL trial.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Low Screening Rates for Lung Cancer Highlight Public Health Priority
March 21st 2024Overall rates for lung cancer screening remain low, despite the US Preventive Services Task Force revising its annual screening recommendation in 2021 by lowering the age of initial screening for current or former smokers and their pack-year history.
Read More